This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

In Global News: Heart Disease Awareness Month, Understanding Aortic Disease in Women, and Cannulae Receive CE Mark

Friday, February 2, 2018

Submitted by



Claire Vernon

Patient Care

Several charities provided free surgeries to 15 Kashmiri children with congenital heart defects at the Fortis Memorial Research Institute in Gurgaon, India.

A man in his 40s discovered that he had a rare congenital heart defect after doctors were unable to access his left coronary system via angiography.

Newborns around the US are being adorned with red hats to raise heart disease awareness during February, which is considered American Heart Month.


Drugs and Devices

The PureFlex™ line of adult arterial cannulae from LivaNova has received the CE Mark.


Research, Trials, and Funding

The first patient has been enrolled in the BELIEVE trial, a postmarket prospective study sponsored by LivaNova to evaluate leaflet motion in patients who have received a commercially approved LivaNova bioprosthetic aortic valve.

Baylor College of Medicine in Texas and the University of Kentucky recently joined the American Heart Association’s Strategically Focused Vascular Disease Research Network as part of a collaborative effort to better understand the differences in aortic disease between men and women.

Add comment

Log in or register to post comments